[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334925-105":59,"doc-detail-334925-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-pan-cancer-analysis-of-epha-family-gene-expression-and-its-association-with-prognosis-tumor-microenvironment-and-therapeutic-targets-original-research","A pan-cancer analysis of EphA family gene expression and its association with prognosis, tumor microenvironment, and therapeutic targets - Original Research","","This original research investigates EphA family gene expression across diverse cancers and evaluates its links to patient prognosis, immune characteristics, and tumor microenvironment (TME). Using The Cancer Genome Atlas (TCGA) as the main resource, the study analyzes relationships with survival outcomes, immunological subtypes, and TME features through multiple R packages. Results identify differential expression for most EphA genes between cancer and non-cancer tissues, with several genes acting as independent prognostic factors. The work also reports EphA associations with immune subtypes and highlights EphA3 as a key prognostic influence in papillary renal cell carcinoma (KIRP).",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-pan-cancer-analysis-of-epha-family-gene-expression-and-its-association-with-prognosis-tumor-microenvironment-and-therapeutic-targets-original-research/334925/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-pan-cancer-analysis-of-epha-family-gene-expression-and-its-association-with-prognosis-tumor-microenvironment-and-therapeutic-targets-original-research/334925.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study examine about EphA genes across cancers?","Question",{"text":112,"@type":113},"It evaluates how EphA family gene expression relates to patient survival, immunological subtypes, and tumor microenvironment characteristics across multiple cancer types.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What key findings were reported about EphA gene expression differences?",{"text":117,"@type":113},"Most EphA genes showed significant expression differences between cancer tissues and non-cancer tissues, and many acted as independent prognostic factors across cancer types.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is EphA3 highlighted in papillary renal cell carcinoma (KIRP)?",{"text":121,"@type":113},"EphA3 independently influences KIRP prognosis and is linked to immune infiltration subtypes and clinicopathologic parameters, suggesting value as a biomarker for predicting outcomes and immunotherapy responsiveness.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334925,1790311267,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","TYPE Original Research PUBLISHED 17 June 2024  \nDOI 10.3389/fonc.2024.1378087  \nOPEN ACCESS  \nEDITED BY Hua Tan,  \nNational Human Genome Research Institute (NIH), United States  \nREVIEWED BY  \nFlorica Sandru,  \nCarol Davila University of Medicine and Pharmacy, Romania  \nRajni Kant Shukla,  \nThe Ohio State University, United States  \n*CORRESPONDENCE Yiping Xiang  \n [xiangyp94@163.com](xiangyp94@163.com)  \n†These authors share ﬁrst authorship  \nRECEIVED 29 January 2024  \nACCEPTED 30 May 2024  \nPUBLISHED 17 June 2024  \nCITATION  \nCui Z, Liu C, Wang X and Xiang Y (2024) A pan-cancer analysis of EphA  \nfamily gene expression and its association with prognosis, tumor microenvironment, and therapeutic targets.  \nFront. Oncol. 14:1378087 .  \ndoi: 10.3389/fonc.2024.1378087  \nCOPYRIGHT  \n© 2024 Cui, Liu, Wang and Xiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nA pan-cancer analysis of EphA family gene expression and its association with prognosis, tumor microenvironment, and therapeutic targets  \nZhe Cui 1†, Chengwang Liu 2†, Xuechao Wang 2† and Yiping Xiang 3*  \n1 Division of Hematology and Transfusion Medicine, Tianjin Baodi Hospital, Tianjin Baodi Afﬁliated Hospital of Tianjin Medical University, Tianjin, China, 2 Department of Laboratory Medicine, Tianjin Baodi Afﬁliated Hospital of Tianjin Medical University, Tianjin, China, 3 Department of Pathology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China  \nBackground: Erythropoietin-producing human hepatocellular (Eph) receptors stand out as the most expansive group of receptor tyrosine kinases (RTKs) . Accumulating evidence suggests that within this expansive family, the EphA subset is implicated in driving cancer cell progression, proliferation, invasion, and metastasis, making it a promising target for anticancer treatment. Nonetheless, the extent of EphA family involvement across diverse cancers, along with its intricate interplay with immunity and the tumor microenvironment (TME), remains to be fully illuminated.  \nMethods: The relationships between EphA gene expression and patient survival, immunological subtypes, and TME characteristics were investigated based on The Cancer Genome Atlas (TCGA) database. The analyses employed various R packages.  \nResults: A signiﬁcant difference in expression was identiﬁed for most EphA genes when comparing cancer tissues and non-cancer tissues . These genes independently functioned as prognostic factors spanning multiple cancer types. Moreover, a signiﬁcant correlation surfaced between EphA gene expression and immune subtypes, except for EphA5, EphA6, and EphA8 . EphA3 independently inﬂuenced the prognosis of papillary renal cell carcinoma (KIRP) . This particular gene exhibited links with immune inﬁltration subtypes and clinicopathologic parameters, holding promise as a valuable biomarker for predicting prognosis and responsiveness to immunotherapy in patients with KIRP.  \nFrontiers in Oncology 01 [frontiersin.org](frontiersin.org)  \nConclusion: By meticulously scrutinizing the panorama of EphA genes in a spectrum of cancers, this study supplemented a complete map of the effect of EphA family in Pan-cancer and suggested that EphA family may be a potential target for cancer therapy.  \nKEYWORDS  \nErythropoietin-producing human hepatocellular (Eph) receptors, pancancer, tumor microenvironment (TME), papillary renal cell carcinoma (KIRP), therapeutic targets, bioinformatics  \nIntroduc","cbCaieqT7U0dkC4P","https://ap.wps.com/l/cbCaieqT7U0dkC4P","pdf",8130908,11,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Introduction\n# EphA family in cancer biology\n# EphA and tumor immune microenvironment","[{\"question\":\"What does the study examine about EphA genes across cancers?\",\"answer\":\"It evaluates how EphA family gene expression relates to patient survival, immunological subtypes, and tumor microenvironment characteristics across multiple cancer types.\"},{\"question\":\"What key findings were reported about EphA gene expression differences?\",\"answer\":\"Most EphA genes showed significant expression differences between cancer tissues and non-cancer tissues, and many acted as independent prognostic factors across cancer types.\"},{\"question\":\"Why is EphA3 highlighted in papillary renal cell carcinoma (KIRP)?\",\"answer\":\"EphA3 independently influences KIRP prognosis and is linked to immune infiltration subtypes and clinicopathologic parameters, suggesting value as a biomarker for predicting outcomes and immunotherapy responsiveness.\"}]","A pan-cancer analysis of EphA family gene expression and its association with prognosis, tumor microenvironment, and therapeutic targets - Original Research | PDF",1790008867,28]